Explore the Latest Cancer Research News and Updates

For 2026, ReMission Foundation is pleased to support Darren Feldman, MD, Section Head for Germ Cell Tumors (GCTs) within the Genitourinary Oncology Service at Memorial Sloan Kettering Cancer Center (MSK), and his innovative research treating testicular cancer. GCTs are responsible for over 95% of cases of testicular cancer and are the most common cancers diagnosed in men ages 15 to 40. GCTs occasionally arise in areas around the thoracic or abdominal cavities, even if there i

For 2025, ReMission Foundation, with the support of Weill Cornell Medicine/NewYork-Presbyterian Hospital, is pleased to support Alana...

For 2024, ReMission Foundation, with the support of White Plains Hospital Cancer Center, is pleased to support Charles M. Noyer MD,...

Scientists at UCLA developed an AI model that helps determine how extensive cancer is within the prostate gland A new study shows that an...

ReMission Foundation, with the support of Memorial Sloan Kettering Cancer Center, is pleased to support Michael J. Morris MD, Prostate...

An Interview With Savio P. Clemente Cancer is a horrible and terrifying disease. Yet millions of people have beaten the odds and beat...

ReMission Foundation will be supporting Cervical Cancer brachytherapy innovation research and development led by Eve McDavid and Dr....

Cervical cancer is the fourth most common cancer among women globally, with an estimated 604,000 new cases and 342,000 deaths in 2020....

About 30% of eligible people are not adequately screened against second most common cancer in women under 35 A drive to encourage women...

There is no guaranteed way to prevent cervical cancer. However, by getting the HPV vaccine and undergoing regular testing, a person can...